ULTRACEMCO.NS · Intrinsic value
Is UltraTech Cement Limited (ULTRACEMCO.NS) overvalued or undervalued?
UltraTech Cement Limited (ULTRACEMCO.NS) trades at the delayed market price of ₹10,650.00 a share. That price already implies revenue growth of 11.3% a year for 5 years. TickerWorth's fair value is ₹9,042.35 a share (18% above fair value), as of Oct 19, 2026. It is a model estimate, and every input behind it is sourced below.
Model by Miraaj Patel · generated from market data · Updated Oct 19, 2026 · How these pages are made
Is ULTRACEMCO.NS overvalued?
- Fair value
- ₹9,042.35
- Market price
- ₹10,650.00
- Downside to fair value
- 15.1%
- Verdict
- 18% above fair value
Reverse DCF: Today's price implies revenue growth of 11.3% a year for 5 years; our model assumes 9.9% a year on average over the same horizon.
What is ULTRACEMCO.NS's TickerWorth Score?
Scores lower than most companies we compare it with
Compared with Basic Materials companies in India
Its strongest point: a profitable, high-quality business. Its weakest: looks expensive on the numbers.
- Value · 33 of 100
Cheaper than 33% of Basic Materials companies in India
- Price vs worth · 38 of 100
- Quality · 59 of 100
More profitable than 59% of Basic Materials companies in India
- Financial health · 42 of 100
Financially stronger than 42% of Basic Materials companies in India
- Growth · 45 of 100
Growing faster than 45% of Basic Materials companies in India
- Momentum · 15 of 100
Outperformed 15% of Basic Materials companies in India over the past year
Confidence: High confidence · Scored
Get the Undervalued Company of the Week.
ULTRACEMCO.NS DCF valuation: what the price assumes
At a recent price of ₹10,650, UltraTech Cement Limited (ULTRACEMCO.NS) trades 18% above TickerWorth's blended fair value of ₹9,042 per share — a discounted-cash-flow model cross-checked against peer multiples and asset value — meaning the market currently prices ULTRACEMCO.NS overvalued vs our estimate of what the business is intrinsically worth. Our fair value sits below the market, an implied -15.1% move to close the gap if the business performs in line with our assumptions. This is an educational model, not a price target or a recommendation — the value moves with the inputs, which you can test yourself using the WACC slider below.
Read the full reasoning
One of the lenses behind that blended figure is a discounted-cash-flow model, which on its own values ULTRACEMCO.NS at about ₹10,313 per share. The rest of this page walks through that DCF — its assumptions, reverse-DCF and discount-rate sensitivity — because it is the auditable anchor of the blend.
The valuation discounts UltraTech Cement Limited's projected free cash flows at a weighted-average cost of capital (WACC) of 7.5%, with a long-run terminal growth rate of 2.5%. About 80% of the enterprise value comes from the terminal value — the portion beyond the explicit forecast window — which is typical for a stable, cash-generative business and a reminder that small changes in the discount rate or terminal growth assumption swing the intrinsic value meaningfully.
Running the DCF in reverse — solving for the growth the current price already assumes — the market is implying roughly 11.3% annual revenue growth for ULTRACEMCO.NS. Our base case instead compounds to about 9.9% a year over the same forecast, so the market's implied growth is broadly in line with our base case. The reverse-DCF is a quick sanity check: it reframes 'is this stock cheap?' as 'do I believe the growth the price requires?' rather than arguing over a single point estimate of fair value.
Sensitivity matters more than any single number. Across a reasonable band of discount-rate assumptions, ULTRACEMCO.NS's modeled DCF value ranges from about ₹6,839 to ₹20,766 per share. If that range still sits below today's price, the market is optimistic relative to the model across the whole band; if it brackets the price, the stock is roughly fairly valued on our assumptions. Use the interactive slider to see exactly where your own cost-of-capital view lands.
How to read this page: the DCF fair value is what UltraTech Cement Limited would be worth if its cash flows grow as modeled and are discounted at the stated WACC. The assumptions table shows every input and its source; the reverse-DCF shows what the market believes; the sensitivity band shows how fragile the answer is. None of this is investment advice — it is a transparent, auditable framework for forming your own view of ULTRACEMCO.NS's intrinsic value. Figures update as new filings and prices come in.
Every input behind ULTRACEMCO.NS's DCF
| Input | Value |
|---|---|
| Base-year revenueLive feed — totalRevenue (TTM) | ₹918,842,770,000 |
| Base EBIT marginComputed — trailing operatingMargins, held roughly flat | 15.5% |
| Forecast revenue growthESTIMATEAssumption — TickerWorth's 5-year explicit forecast | 16% → 13% → 10% → 7% → 4% |
| Risk-free rateLive feed — US 10-year Treasury yield (^TNX) | 5.3% |
| BetaLive feed — yfinance, 5-year monthly beta vs the S&P 500 (clamped to 0.4–2.5) | 0.49 |
| Terminal growthESTIMATEAssumption — TickerWorth house default 2.5%, held below WACC | 2.5% |
| Diluted sharesLive feed — sharesOutstanding | 294M |
| Market priceLast known price · as of 2026-10-19 21:03 UTC | ₹10,650 |
Change ULTRACEMCO.NS's assumptions
The discount-rate dial and the editable model
ProChange growth, margin and WACC yourself — Pro (7-day free trial, card required).
What does UltraTech Cement Limited do?
What does it do?
UltraTech Cement Limited, together with its subsidiaries, engages in the manufacturing, marketing, and distribution of building materials in India and internationally. It offers grey cement, including ordinary Portland, composite, and weather plus, as well as Portland pozzolana, pozzolana super, and slag cement; white cement, wall care putty, and value-added products; and ready-mix concrete. It operates in the Building Materials industry (Basic Materials sector), headquartered in India. The company employs roughly 28,399 people.
How does it make money?
The business turns 918.8B in annual revenue into profit. Out of every $100 of sales, about $15 is left as operating profit (operating margin of 15.5%), after a 58% gross margin on the products/services it sells. After all costs, taxes and interest, 9.3% of revenue becomes bottom-line net profit.
Is it financially healthy?
Financially it looks mixed: carries modest debt (0.3× equity), and is currently profitable.
ULTRACEMCO.NS insider trading
Insider filings are available for US-listed companies only.
Common questions
What is ULTRACEMCO.NS's intrinsic value?
TickerWorth's blended fair value for UltraTech Cement Limited (ULTRACEMCO.NS) is ₹9,042 per share, versus a market price of ₹10,650 (18% above fair value).
Is ULTRACEMCO.NS overvalued or undervalued?
On our blended fair value ULTRACEMCO.NS looks overvalued vs fair value at ₹10,650. This is an educational estimate, not advice.
What discount rate is used for ULTRACEMCO.NS?
A WACC of 7.5% and a terminal growth rate of 2.5%.
Is UltraTech Cement stock undervalued?
TickerWorth's fair value for UltraTech Cement Limited (ULTRACEMCO.NS) is ₹9,042.35 against a market price of ₹10,650.00. Our read: 18% above fair value. This is a model estimate, not investment advice.
UltraTech Cement (ULTRACEMCO.NS) DCF valuation and fair value
Our fair value for UltraTech Cement Limited (ULTRACEMCO.NS) is ₹9,042.35, built on a 7.5% discount rate (WACC) and 2.5% terminal growth. It blends our discounted-cash-flow model with other valuation lenses. Every assumption is listed on this page with its source.
What growth is priced into UltraTech Cement stock?
Today's price implies revenue growth of 11.3% a year for 5 years; our model assumes 9.9% a year on average over the same horizon. This is a reverse DCF: it holds our cash-flow model's other inputs and solves for the revenue growth that makes the model equal today's price of ₹10,650.00. A model estimate, not investment advice.
UltraTech Cement (ULTRACEMCO.NS) insider trading
We have no recent SEC Form 4 insider filings on file for UltraTech Cement Limited (ULTRACEMCO.NS). Form 4 covers US-listed companies only.
Stocks below our fair value instead
Not investment advice. TickerWorth Score is a model output.
Educational tool. Every output reflects the assumptions shown — not a prediction and not investment advice. TickerWorth is not a licensed investment adviser, and these figures are estimates from public filings and market data that can be wrong.